Moderna, Inc.
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the Uni…
Biotechnology
US, Cambridge [HQ]
Balance Sheet
8 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | 1,417.00 | 1,084.00 | 1,962.00 | 1,589.00 | 7,336.00 | 24,669.00 | 25,858.00 | 18,426.00 | |
|
Current
|
1,087.00 | 783.00 | 1,563.00 | 1,262.00 | 6,297.00 | 17,570.00 | 13,431.00 | 10,325.00 | |
| Cash And Equivalents | 50.00 | 134.00 | 658.00 | 235.00 | 2,623.00 | 6,848.00 | 3,205.00 | 2,907.00 | |
| Assets | 1,417.00 | 1,084.00 | 1,962.00 | 1,589.00 | 7,336.00 | 24,669.00 | 25,858.00 | 18,426.00 | |
| Accounts Receivables (AR) | 52.00 | - - | - - | 7.00 | -1,385.00 | -1,784.00 | 1,790.00 | 493.00 | |
| Inventory | - - | - - | -172.00 | -904.00 | 46.00 | 1,441.00 | 949.00 | 202.00 | |
| Short Term Investments | 1,008.00 | 621.00 | 863.00 | 867.00 | 1,983.00 | 3,879.00 | 6,697.00 | 5,697.00 | |
| Other Current Assets | 11.00 | 10.00 | 10.00 | 887.00 | -405.00 | 55.00 | 1,195.00 | 88.00 | |
|
Non Current
|
330.00 | 301.00 | 399.00 | 326.00 | 1,038.00 | 7,099.00 | 12,427.00 | 8,101.00 | |
| Property, Plant, Equipment (Net) | 81.00 | 139.00 | 211.00 | 287.00 | 387.00 | 1,383.00 | 2,139.00 | 2,658.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | - - | - - | - - | 44.00 | |
| Goodwill | - - | - - | - - | - - | - - | - - | - - | 52.00 | |
| Long Term Investments | 236.00 | 145.00 | 172.00 | 159.00 | 638.00 | 6,843.00 | 8,318.00 | 4,743.00 | |
| Other Non Current Assets | 12.00 | 16.00 | 14.00 | -121.00 | 12.00 | 46.00 | 988.00 | 523.00 | |
| Liabilities | 575.00 | 459.00 | 431.00 | 414.00 | 4,775.00 | 10,524.00 | 6,735.00 | 4,572.00 | |
|
Current
|
162.00 | 191.00 | 222.00 | 143.00 | 4,388.00 | 9,128.00 | 4,923.00 | 3,015.00 | |
| Accounts Payable | 5.00 | -12.00 | 15.00 | -23.00 | 11.00 | 204.00 | 240.00 | 13.00 | |
| Short Term Debt | 25.00 | 72.00 | 79.00 | 67.00 | 469.00 | 211.00 | 196.00 | 25.00 | |
| Deferred Revenue | 107.00 | 96.00 | 109.00 | 63.00 | 3,867.00 | 6,253.00 | 2,038.00 | 568.00 | |
| Tax Payable | - - | - - | - - | - - | - - | 876.00 | 48.00 | 63.00 | |
| Other Current Liabilities | 1.00 | 1.00 | 3.00 | 5.00 | 33.00 | 2,362.00 | 2,202.00 | 1,902.00 | |
|
Non Current
|
412.00 | 267.00 | 209.00 | 271.00 | 386.00 | 1,396.00 | 1,812.00 | 1,557.00 | |
| Long Term Debt | 12.00 | 15.00 | 33.00 | 132.00 | 207.00 | 705.00 | 1,004.00 | 1,218.00 | |
| Leasing Obligations | 12.00 | 15.00 | 33.00 | 132.00 | 207.00 | 916.00 | 1,004.00 | 1,243.00 | |
| Deferred Non Current Tax Liabilities | 4.00 | 7.00 | 10.00 | - - | - - | 200.00 | 229.00 | - - | |
| Other Non Current Liabilities | 1.00 | 1.00 | - - | - - | 1.00 | -124.00 | -94.00 | 256.00 | |
| Equity | 841.00 | 625.00 | 1,530.00 | 1,174.00 | 2,561.00 | 14,145.00 | 19,123.00 | 13,854.00 | |
| Stockholders' Equity | 841.00 | 625.00 | 1,530.00 | 1,174.00 | 2,561.00 | 14,145.00 | 19,123.00 | 13,854.00 | |
| Retained Earnings | -365.00 | -621.00 | -1,006.00 | -1,496.00 | -2,243.00 | 9,958.00 | 18,320.00 | 13,606.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | 1,176.00 | 1,176.00 | 1,962.00 | - - | - - | - - | - - | - - | |
| Profit | -216.00 | -255.00 | -384.00 | -514.00 | -747.00 | 12,202.00 | 8,362.00 | -4,714.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | 31.00 | 71.00 | 576.00 | 2,669.00 | 4,801.00 | 4,211.00 | 1,173.00 | 371.00 | |
| Loss Other Compr. Income | - - | -1.00 | -1.00 | 1.00 | 3.00 | -24.00 | -370.00 | -123.00 |